Rybelsus Tablets 14mg, from Novo Nordisk Pharma, contain Semaglutide (genetical recombination) and are used to help manage type 2 diabetes in adults when diet and exercise are insufficient. It aids in lowering blood sugar by stimulating insulin, suppressing glucagon, and delaying gastric emptying. YJ code: 2499014F3024, Standard: 14mg 1 tablet.
Rybelsus Tablets 14mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →